Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
PMDA is regarded among the most stringent regulatory bodies globally
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
The license is valid for five years, effective from April 9, 2026
Final approval for progesterone vaginal inserts expands Glenmark’s women’s healthcare portfolio in the US, targeting a market of over $59 million
AI challenge offers Rs 10 lakh top prize and potential ?50 lakh deployment contract; applications open till April 17
Immediate U.S. launch planned for Farxiga®-equivalent diabetes drug; opportunity pegged at $10.2 billion in annual market size
Subscribe To Our Newsletter & Stay Updated
